F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas

References

• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Mature T and NK cell neoplasms, E SRE Jaffe. IARC Press, Lyon 2001
   Google Scholar
• Armitage J O, Vose J M, Weisenburger D D. Towards understanding the peripheral T-cell lymphomas. Ann Oncol 2004; 15: 1447–1449
   PubMed Web of Science ®Google Scholar
• Evens A M, Gartenhaus R B. Treatment of T-cell non-Hodgkin's lymphoma. Curr Treat Options Oncol 2004; 5: 289–303
   PubMedGoogle Scholar
• Juweid M E, Stroobants S, Hoekstra O S, Mottaghy F M, Dietlein M, Guermazi A, Wiseman G A, Kostakoglu L, Scheidhauer K, Buck A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571–578
   PubMed Web of Science ®Google Scholar
• Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio J A, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101: 3875–3876
   PubMed Web of Science ®Google Scholar
• Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004; 34: 166–179
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe E S, Burg G, Cerroni L, Berti E, Swerdlow S H, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785
   PubMed Web of Science ®Google Scholar
• Armitage J O. Staging non-Hodgkin lymphoma. CA Cancer J Clin 2005; 55: 368–376
   PubMed Web of Science ®Google Scholar
• Lamberg S I, Bunn P A, Jr. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol 1979; 115: 1103–1105
   PubMed Web of Science ®Google Scholar
• Delbeke D CR, Guiberteau M J, Brown M L, Royal H D, Seigel B A, Townsend D W, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. Society of Nuclear Medicine Procedure Guidelines. 2006
   Google Scholar
• Miller E, Metser U, Avrahami G, Dvir R, Valdman D, Sira L B, et al. Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients. J Comput Assist Tomogr 2006; 30: 689–694
   PubMed Web of Science ®Google Scholar
• Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al. 2-(Fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001; 91: 889–899
   PubMed Web of Science ®Google Scholar
• Tatsumi M, Cohade C, Nakamoto Y, Fishman E K, Wahl R L. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology 2005; 237: 1038–1045
   PubMed Web of Science ®Google Scholar
• Kostakoglu L, Leonard J P, Kuji I, Coleman M, Vallabhajosula S, Goldsmith S J. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002; 94: 879–888
   PubMed Web of Science ®Google Scholar
• Rizvi M A, Evens A M, Tallman M S, Nelson B P, Rosen S T. T-cell non-Hodgkin lymphoma. Blood 2006; 107: 1255–1264
   PubMed Web of Science ®Google Scholar
• Kumar R, Xiu Y, Zhuang H M, Alavi A. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma. Br J Dermatol 2006; 155: 357–363
   PubMed Web of Science ®Google Scholar
• Tsai E Y, Taur A, Espinosa L, Quon A, Johnson D, Dick S, et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 2006; 142: 577–584
   PubMed Web of Science ®Google Scholar
• Valencak J, Becherer A, Der-Petrossian M, Trautinger F, Raderer M, Hoffmann M. Positron emission tomography with [18F] 2-fluoro-d-2-deoxyglucose in primary cutaneous T-cell lymphomas. Haematologica 2004; 89: 115–116
   PubMed Web of Science ®Google Scholar
• Howlett D C, Wong W L, Smith N P, Ayers A B. Computed tomography in the evaluation of cutaneous T-cell lymphoma. Eur J Radiol 1995; 20: 39–42
   PubMed Web of Science ®Google Scholar
• Bass J C, Korobkin M T, Cooper K D, Kane N M, Platt J F. Cutaneous T-cell lymphoma: CT in evaluation and staging. Radiology 1993; 186: 273–278
   PubMed Web of Science ®Google Scholar
• Miketic L M, Chambers T P, Lembersky B C. Cutaneous T-cell lymphoma: value of CT in staging and determining prognosis. AJR Am J Roentgenol 1993; 160: 1129–1132
   PubMed Web of Science ®Google Scholar
• Kulin P A, Marglin S I, Shuman W P, Chew D E, Olerud J E. Diagnostic imaging in the initial staging of mycosis fungoides and Sezary syndrome. Arch Dermatol 1990; 126: 914–918
   PubMed Web of Science ®Google Scholar
• Wohrer S, Chott A, Drach J, Puspok A, Hejna M, Hoffmann M, et al. Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Ann Oncol 2004; 15: 1680–1683
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Vogelsang H, Kletter K, Zettinig G, Chott A, Raderer M. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 2003; 52: 347–351
   PubMed Web of Science ®Google Scholar
• Hadithi M, Mallant M, Oudejans J, van Waesberghe J H, Mulder C J, Comans E F. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006; 47: 1622–1627
   PubMed Web of Science ®Google Scholar
• Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?. J Clin Oncol 2001; 19: 414–419
   PubMed Web of Science ®Google Scholar
• Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13: 1356–1363
   PubMed Web of Science ®Google Scholar
• Shapiro M, Yun M, Junkins-Hopkins J M, Vittorio C C, Schulman N, Saidman B H, et al. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. J Am Acad Dermatol 2002; 47: 623–628
   PubMed Web of Science ®Google Scholar
• Meignan M, Haioun C, Itti E, Rahmouni A, Reyes F. Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma 2006; 6: 306–313
   PubMedGoogle Scholar